
NEOK Bio
· Biotechnology
Pharmaceuticals
Biotechnology
Healthcare
NEOK Bio is dedicated to advancing cancer treatment through cutting-edge innovation in antibody drug conjugates (ADCs). Partnering with ABL Bio, a leader in antibody engineering, NEOK is developing bispecific ADCs to improve patient outcomes. Our approach aims to overcome limitations of conventional ADCs with a dual-targeting strategy, offering potential for improved safety and efficacy in treating solid tumor cancers.
2025
Founded
Biotechnology
Industry
-
Location
618,915,723
Ranking
0 employees
Size

Get full access to view complete information

© 2026 Pubrio. All rights reserved.